RHY logo

Rhythm Biosciences Limited Stock Price

ASX:RHY Community·AU$68.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

RHY Share Price Performance

AU$0.21
0.13 (150.00%)
AU$0.21
0.13 (150.00%)
Price AU$0.21

RHY Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with mediocre balance sheet.

5 Risks
0 Rewards

Rhythm Biosciences Limited Key Details

AU$1.6m

Revenue

AU$634.9k

Cost of Revenue

AU$1.0m

Gross Profit

AU$7.7m

Other Expenses

-AU$6.7m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.02
61.47%
-405.14%
9.8%
View Full Analysis

About RHY

Founded
2017
Employees
n/a
CEO
David Atkins
WebsiteView website
rhythmbio.com

Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia.

Recent RHY News & Updates

Recent updates

No updates